Brain Proteomics

269

[59] Y. Jang, O. Pletnikova, J. C. Troncoso, et al., “Mass spectrometry–based

proteomics analysis of human substantia nigra from parkinson’s disease

patients identifies multiple pathways potentially involved in the disease,”

Molecular & Cellular Proteomics, vol. 22, no. 1, 2023.

[60] V. A. Petyuk, L. Yu, H. M. Olson, and o. Yu, “Proteomic profiling of the

substantia nigra to identify determinants of lewy body pathology and

dopaminergic neuronal loss,” Journal of proteome research, vol. 20, no. 5,

pp. 2266–2282, 2021.

[61] S. Plum, B. Eggers, S. Helling, et al., “Proteomic characterization of

synaptosomes from human substantia nigra indicates altered mitochon-

drial translation in parkinson’s disease,” Cells, vol. 9, no. 12, p. 2580,

2020.

[62] M. G. Sürmen, S. Sürmen, D. Cansız, et al., “Quantitative phosphopro-

teomics to resolve the cellular responses to octanoic acid in rotenone ex-

posed zebrafish,” Journal of Food Biochemistry, vol. 45, no. 10, p. e13923,

2021.

[63] M. G. Sürmen, S. Sürmen, D. Cansız, et al., “Amelioration of rotenone-

induced alterations in energy/redox system, stress response and cy-

toskeleton proteins by octanoic acid in zebrafish: A proteomic study,”

Journal of Biochemical and Molecular Toxicology, vol. 36, no. 5, p. e23024,

2022.

[64] İ. Ünal, D. Cansız, M. G. Sürmen, et al., “Identification of molecular net-

work of gut-brain axis associated with neuroprotective effects of pparδ-

ligand erucic acid in rotenone-induced parkinson’s disease model in ze-

brafish,” European Journal of Neuroscience, vol. 57, no. 4, pp. 585–606,

2023.

[65] M. S. Rotunno, M. Lane, W. Zhang, et al., “Cerebrospinal fluid pro-

teomics implicates the granin family in parkinson’s disease,” Scientific

reports, vol. 10, no. 1, p. 2479, 2020.

[66] Y. Zhao, Y. Zhang, J. Zhang, et al., “Plasma proteome profiling using

tandem mass tag labeling technology reveals potential biomarkers for

parkinson’s disease: a preliminary study,” PROTEOMICS–Clinical Ap-

plications, vol. 16, no. 2, p. 2100010, 2022.

[67] R. Jiang, C. Rong, R. Ke, et al., “Differential proteomic analysis of

serum exosomes reveals alterations in progression of parkinson disease,”

Medicine, vol. 98, no. 41, 2019.

[68] S. Virreira Winter, O. Karayel, M. T. Strauss, et al., “Urinary proteome

profiling for stratifying patients with familial parkinson’s disease,” EMBO

molecular medicine, vol. 13, no. 3, p. e13257, 2021.